AMGN trade ideas
$AMGN Good results might not be good enough. Cautious.Despite FDA approval for Amgen's new Enrel drug last week we see the bounce as the formation of a bear flag heading into earnings. Sentiment is so poor in the sector we fear that regardless of results the stock will eventually continue to drop. Amgen is very cheap at 14 P/E ratio with an average rating of HOLD among 25 analysts covering the name.
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate and Parsabiv.
Buy at supportI'm buying AMGN at long term support. There is still a high chance of a phase 4 hyperwave that will take this much much higher. S/L 170
Amgen Inc (AMGN)For the full year sales increased 4.0% to 23.7 billions, with a net profit of 9.57 billions. Total debt: 34.0 billions. The company product's innovation is very intense, currenty has 10 firt-in-human molecules in clinical development.
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The TreatmentAMGN: Amgen
2019-04-09 15:57:00
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture - PR Newswire
Double top for AMGNI believe this is a confirmed double top for AMGN, which is the end for its nice run up that began with a double bottom..
I will look into this stock after a $18-25 pull back...
AMGN Downtrend Current Downtrend, this could range for awhile. I do enjoy trading this ticker, ill consider taking short positions near top of downtrend line but I don't plan on taking long positions until the trend changes.
AMGEN Misses$AMGN At trendline support. A break would be bearish, possibly setting up a move back to the origin of the entire advance.
AMGN - trade setupLike this gap down.. I'll wait for the first 5 min candle and play the break of that. Since this is a red candle gaping down it could retest then roll over.c Might take a few min to really break down or just head fake and go back up.
FDA Approves Nplate® (Romiplostim) For Use In Pediatric PatientsAMGN: Amgen
2018-12-14 16:00:00
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
AMGN - Amgen Stock SpeculationHere we have Amgen Stock chart. Bigger picture suggesting that there is more room to fall until we reach significant areas of demand. As we move to the lower time frame we can see fresh supply sitting above and very little demand below. Will look for an entry here.
[AMGEN] Phase 2 but starting phase 3?If in monday the price break the support so it's starting phase 3.
Observing AMGEN Inc (Biotech company)I've drawn some levels based on VolumeProfileMarket of current "expiration session". Let's see how it will behave. Probably I will try even to enter to it
AMGN is expected to increase further... The target price of the current exchange rate is around 231 usd. We expect an ABC waveform correction from the level. The endpoint of this correction is a D1 ATR axis around 190 usd. There is a further rise in the level of this level.
Tezepelumab Granted Breakthrough Therapy Designation By US FDAAMGN : Amgen
2018-09-07 02:00:00
Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
